Oubidar M, Marie C, Mossiat C, Bralet J
Laboratoire de Pharmacodynamie, Faculté de Pharmacie, Dijon, France.
J Mol Cell Cardiol. 1996 Aug;28(8):1769-76. doi: 10.1006/jmcc.1996.0166.
Elevation of cell iron content was produced by use of a lipophilic iron ligand, 8-hydroxyquinoline (HQ), capable of transferring catalytically active iron into cells. The Fe(3+)-HQ complex labeled with 59Fe was avidly taken up by isolated perfused hearts contrary to the hydrophilic complex Fe(3+)-citrate. Hearts perfused in aerobic conditions with Krebs-Henseleit buffer were exposed for 15 min to the iron complexes, Fe(3+)-HQ (5 microM/10 microM and 10 microM/20 microM), or Fe(3+)-citrate (10 microM), and then perfused for 30 min with normal buffer. Exposure to the high dose of Fe(3+)-HQ (10 microM/20 microM) resulted in early and irreversible decreases in coronary flow and heart rate (-48% and -33%, respectively), initial increases followed by decreases in left ventricular systolic pressure and +dP/dt, and increase in left ventricular end-diastolic pressure (+80%). The low dose of Fe(3+)-HQ (5 microM/10 microM) mimicked with a lower magnitude the effects of the high dose, whereas Fe(3+)-citrate had no effects on cardiac parameters. Only hearts exposed to the high dose of Fe(3+)-HQ exhibited a significant increase (+60%) in thiobarbituric acid-reactive substance level, an index of lipid peroxidation. The production of hydroxyl radicals was investigated by measuring 2,3-dihydroxybenzoic acid level in the coronary effluent after addition of salicylic acid (1 mM) in the perfusate. An immediate and high increase (x6) was seen during heart exposure to Fe(3+)-HQ (10 microM/20 microM) and to Fe(3+)-citrate (10 microM). Considering Fe(3+)-citrate had no effect on cardiac function and lipid peroxidation it was concluded that this hydroxyl radical formation occurring in the extracellular space was not implicated in Fe(3+)-HQ-induced cardiac dysfunction. These results demonstrate the deleterious effect of increasing intracellular reactive iron level in non-ischemic hearts.
通过使用亲脂性铁配体8-羟基喹啉(HQ)来提高细胞铁含量,该配体能够将具有催化活性的铁转运到细胞中。与亲水性复合物Fe(3+)-柠檬酸盐相反,用59Fe标记的Fe(3+)-HQ复合物被离体灌注心脏大量摄取。在有氧条件下用Krebs-Henseleit缓冲液灌注的心脏暴露于铁复合物Fe(3+)-HQ(5 microM/10 microM和10 microM/20 microM)或Fe(3+)-柠檬酸盐(10 microM)15分钟,然后用正常缓冲液灌注30分钟。暴露于高剂量的Fe(3+)-HQ(10 microM/20 microM)导致冠状动脉血流量和心率早期且不可逆地下降(分别为-48%和-33%),左心室收缩压和 +dP/dt 先升高后降低,以及左心室舒张末期压力升高(+80%)。低剂量的Fe(3+)-HQ(5 microM/10 microM)以较低程度模拟了高剂量的作用,而Fe(3+)-柠檬酸盐对心脏参数没有影响。只有暴露于高剂量Fe(3+)-HQ的心脏硫代巴比妥酸反应性物质水平显著升高(+60%),这是脂质过氧化的一个指标。通过测量在灌注液中加入水杨酸(1 mM)后冠状动脉流出液中2,3-二羟基苯甲酸水平来研究羟基自由基的产生。在心脏暴露于Fe(3+)-HQ(10 microM/20 microM)和Fe(3+)-柠檬酸盐(10 microM)期间立即出现大幅升高(x6)。考虑到Fe(3+)-柠檬酸盐对心脏功能和脂质过氧化没有影响,得出的结论是,在细胞外空间发生的这种羟基自由基形成与Fe(3+)-HQ诱导的心脏功能障碍无关。这些结果证明了增加非缺血心脏细胞内活性铁水平的有害作用。